• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxamides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxamides

Introduction to 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide (CAS No. 68373-65-9)

4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide, identified by its Chemical Abstracts Service (CAS) number 68373-65-9, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the dihydropyridine class, a family of molecules known for their diverse biological activities and applications in drug development. The structural features of 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide include a pyridine ring with hydroxyl, methyl, and carboxamide functional groups, which contribute to its unique chemical properties and potential biological functions.

The synthesis and characterization of 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide have been extensively studied due to its relevance in the development of novel therapeutic agents. The compound’s molecular structure suggests that it may exhibit properties such as kinase inhibition, anti-inflammatory effects, or even anticancer activities. These possibilities have driven researchers to explore its pharmacological potential further.

In recent years, advancements in computational chemistry and high-throughput screening techniques have enabled more efficient identification of bioactive molecules. 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide has been utilized in virtual screening campaigns to identify lead compounds for various diseases. Its scaffold has been modified to enhance potency and selectivity, leading to the discovery of several promising derivatives. These derivatives are being evaluated in preclinical studies to assess their safety and efficacy.

The carboxamide group in 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide plays a crucial role in determining its reactivity and interaction with biological targets. This moiety is frequently found in drugs due to its ability to form hydrogen bonds and participate in salt formation, which can improve solubility and bioavailability. Researchers have leveraged this property to design molecules that can interact with specific enzymes or receptors more effectively.

One of the most exciting areas of research involving 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide is its potential application in treating neurological disorders. Dihydropyridines are known for their ability to modulate calcium channels, which are critical for neuronal function. Studies suggest that derivatives of this compound may have neuroprotective effects by influencing calcium signaling pathways. This has opened up new avenues for developing treatments for conditions such as Alzheimer’s disease and Parkinson’s disease.

The hydroxyl group in the molecule also contributes to its versatility. It can be further functionalized through various chemical reactions, allowing researchers to tailor the compound’s properties for specific applications. For instance, etherification or esterification of the hydroxyl group can alter the compound’s metabolic stability and pharmacokinetic profile.

Another area where 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide shows promise is in anti-inflammatory drug development. Chronic inflammation is a hallmark of many diseases, including cardiovascular disorders and autoimmune conditions. The compound’s ability to interact with inflammatory pathways has been explored in several laboratory studies. By modulating key enzymes involved in inflammation, such as COX or LOX enzymes, this molecule could potentially reduce inflammation without the side effects associated with traditional anti-inflammatory drugs.

The synthesis of 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include condensation reactions between appropriate precursors followed by cyclization and functional group modifications. Advances in green chemistry have also led to the development of more sustainable synthetic methods that minimize waste and reduce environmental impact.

In conclusion, 4-hydroxy-6-methyl - 2 - oxo - 1 , 2 - dihydrop y rid ine - 3 - carbox am ide (CAS No. 68373 - 65 - 9) is a versatile compound with significant potential in pharmaceutical research. Its unique structural features make it a valuable scaffold for developing novel drugs targeting various diseases. As research continues to uncover new applications for this molecule, it is likely that we will see more derivatives entering clinical trials and eventually becoming part of our therapeutic arsenal against some of the most challenging medical conditions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)